Similarly, Wnt/β-catenin signaling was closely associated with calpain isoform Capn4, which induced cell invasion of GC by promoting MMP9 expression, suggesting that Capn4 could be a possible therapeutic target for GC patients [55]. Here, MMP9 is linked to gastric cancer.